Crossmark

Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease

Crossref DOI link: https://doi.org/10.1007/s10067-018-4353-2

Published Online: 2018-11-03

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cobo-Ibáñez, Tatiana

López-Longo, Francisco-Javier

Joven, Beatriz

Carreira, Patricia E.

Muñoz-Fernández, Santiago

Maldonado-Romero, Valentina

Larena-Grijalba, Carmen

Cubas, Irene Llorente

Muriel, Eva Tomero

Mateos, Carmen Barbadillo

de la Peña Lefebvre, Paloma García

Gomez-Gomez, Alejandro

Nogal, Laura Barrio

Pérez, Ana

Almodovar, Raquel

Lojo, Leticia

Ruiz-Gutiérrez, Lucía

López-Robledillo, Juan Carlos

García de Yébenes, María Jesús

Nuño-Nuño, Laura
Funding

Funding for this research was provided by:

MSD
License Information

Text and Data Mining valid from 2018-11-03
More Information

Article History

Received: 26 June 2018

Revised: 30 September 2018

Accepted: 26 October 2018

First Online: 3 November 2018

Compliance with ethical standards

:

: NoneEthical approvalThis study was approved by the ethics committees of the participant hospitals and carried out in compliance with the Helsinki Declaration.